Charles River(US:CRL) ZACKS·2025-08-11 14:15Core Insights - Charles River Laboratories (CRL) reported total revenue of $1.03 billion for the quarter ending June 2025, reflecting a 0.6% increase year-over-year [4] International Revenue Performance - Canada generated $135.59 million, accounting for 13.1% of total revenue, exceeding the consensus estimate by 26.56% [5] - Other International markets, including Brazil and Israel, contributed $10.33 million, representing 1% of total revenue, with a surprise of 148.27% compared to expectations [6] - Asia Pacific revenues were $54.5 million, making up 5.3% of total revenue, surpassing projections by 9.44% [7] - Europe accounted for $281.86 million, or 27.3% of total revenue, with a surprise of 9.29% over analyst expectations [8] Future Revenue Forecasts - Analysts predict total revenue of $960.79 million for the current fiscal quarter, a decline of 4.9% year-over-year, with regional contributions expected from Canada (11.8%), Other International (0.5%), Asia Pacific (4.3%), and Europe (25.6%) [9] - For the full year, total revenue is projected at $3.96 billion, indicating a 2.2% decrease from the previous year, with regional shares expected to be Canada (11.6%), Other International (0.9%), Asia Pacific (4.7%), and Europe (25.7%) [10] Market Context - The company's reliance on international markets presents both opportunities and challenges, necessitating close monitoring of international revenue trends to forecast future performance [12] - In the context of increasing global interdependencies and geopolitical tensions, analysts are focused on these trends to refine earnings predictions [13]